Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Determinant
Covidom
COVID-19 vaccines
Attitude to health
Influenza
Booster response
Healthcare workers
Dose escalation
EMA
Data sharing
Determinants
Digital health intervention
1790GAHB F
Covid-19
Efficacy
Misinformation
Vaccine acceptance
Care management
Co-morbidities
Biomarkers
Immunization
Internet
Vaccine hesitancy
Drug
Antiviral therapy
HPV vaccine
Boys
Effectiveness
Sleep
Alpha variant
Cost of illness
Influenza-like illness
Clinical trials
HIV
Delphi study
Adverse effects
Dialysis
AON
Cancer
Immunocompromised
Acute kidney injury
Vaccine effectiveness
Clinical skills
Practices
Attitudes
Déterminants
Epidemiology
Antiviral agents
Adults
Vaccine
Calcium phosphorus evaluation
Diabetes mellitus type 2
DMD
Attitude
Conditional marketing authorization
Elderly
Awareness
Digital care
COVID-19
Cohort study
Attitudes of health personnel
Dendritic cells
AIDS
Confidence
SARS-CoV-2
Conjugate pneumococcal vaccine
Innate immunity
Coronavirus
Deletion
CERVICOVAGINAL SECRETIONS
Disinformation
Adenoviral vector
Clinical research
Immunogenicity
Chronic kidney disease
Assay
Risk factors
AstraZeneca vaccine
Catch-up
Coadministration
C-type lectin receptor
ANTIRETROVIRAL THERAPY
Antiviral
Antiretroviral therapy
Cystic fibrosis
Respiratory syncytial virus
B-lymphocytes
EHealth literacy
Vaccine safety and efficacy
Vaccination
Covid 19
Chemotherapy
Cohort
Vaccines
Hesitancy
Clinical practice
Incidence
Adjuvant
France
COCONEL cohort surveys